| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.078 | 0.1 |